Gamida Cell Ltd Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Gamida Cell Ltd inventory turnover ratio, the Gamida Cell Ltd 's ability to sell and replace its inventory in the first quarter 2024, sequentially increased to 1.1 in the first quarter 2024, a new company high. Average inventory processing period, for the Gamida Cell Ltd in Mar 31 2024 quarter, has decreased to 332 days, compare to 415 days, in the Dec 31 2023 quarter.

Within Healthcare sector 332 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the fourth quarter 2023, to 1963.

GMDA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Gamida Cell Ltd Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GMDA Inventory Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Inventory Growth	-	-	-	-	-
Y / Y Cost of Sales Growth	-	-	-	-	-
Inventory Turnover Ratio (TTM)	1.1	0.88	0.53	-	-
GMDA's Total Ranking	# 1963	#	#	#	#
Average inventory processing period	331	415	687	-	-
Seq. Inventory Growth	3.15 %	-17.99 %	-2.76 %	-	-
Seq. Cost of Sales Growth	10.63 %	32.27 %	-	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 21
Healthcare Sector	# 333
Overall Market	# 1963

Inventory Turnover Ratio Statistics
High	Average	Low
1.1	1.1	1.1
(Mar 31 2024)

GMDA Company Profile >> Back to GMDA Efficiency Comparisons >> Compare GMDA Inventory Turnover Ratio to its Competitors

Financial Statements
Gamida Cell Ltd 's Inventories	$ 2 Millions	Visit GMDA's Balance sheet
Gamida Cell Ltd 's Cost of Revenues TTM	$ 2 Millions	Visit GMDA's Income Statement
What are GMDA's Sales?		Visit GMDA's Sales by Segment

Other Inventory Turnover Ratios
Gamida Cell Ltd 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GMDA's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GMDA's Competitors
Inventory Turnover Ratio for GMDA's Suppliers
Inventory Turnover Ratio for GMDA's Customers

You may also want to know
GMDA's Sales Growth Rates	GMDA's Pe Price to earnings ratio	GMDA's Receivables Turnover Ratio	GMDA's Stock Quote
GMDA's Net Income Growth Rates	GMDA's Ps Price to Sales ratio	GMDA's Sales per Employee	GMDA's Asset Turnover Ratio
GMDA's Net Margin	GMDA's Pb Price to Book ratio	GMDA's Financial Strength Ratios	GMDA's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2024	Inventories at quarter ending Mar 31 2024
Akebia Therapeutics Inc	3.29	$ 66.270 Millions	$ 20 Millions
Inmed Pharmaceuticals Inc	3.27	$ 3.941 Millions	$ 1 Millions
3m Company	3.25	$ 15,607.000 Millions	$ 4,797 Millions
Sunshine Biopharma Inc	3.22	$ 17.874 Millions	$ 6 Millions
Electromedical Technologies Inc	3.21	$ 0.288 Millions	$ 0 Millions
Strata Skin Sciences Inc	3.17	$ 13.821 Millions	$ 4 Millions
Sanuwave Health Inc	3.17	$ 6.357 Millions	$ 2 Millions
Prestige Consumer Healthcare Inc	3.16	$ 500.000 Millions	$ 158 Millions
Agilent Technologies inc	3.15	$ 3,254.000 Millions	$ 1,034 Millions
Nexgel Inc	3.11	$ 3.782 Millions	$ 1 Millions
Orasure Technologies Inc	3.11	$ 173.852 Millions	$ 56 Millions
Celularity Inc	3.11	$ 15.653 Millions	$ 5 Millions
Maravai Lifesciences Holdings Inc	3.10	$ 153.402 Millions	$ 49 Millions
Inspire Medical Systems inc	3.08	$ 100.112 Millions	$ 32 Millions
Neogen Corporation	3.07	$ 453.991 Millions	$ 148 Millions
Bausch Health Companies Inc	3.07	$ 2,575.000 Millions	$ 840 Millions
Inotiv Inc	3.06	$ 157.844 Millions	$ 52 Millions
Logicmark Inc	3.02	$ 3.167 Millions	$ 1 Millions
Baxter International Inc	3.00	$ 8,017.000 Millions	$ 2,669 Millions
Aquestive Therapeutics Inc	2.98	$ 20.483 Millions	$ 7 Millions
Msa Safety Inc	2.97	$ 936.000 Millions	$ 315 Millions
Alnylam Pharmaceuticals Inc	2.97	$ 281.397 Millions	$ 95 Millions
Mettler toledo International Inc	2.95	$ 1,130.343 Millions	$ 383 Millions
Sonoma Pharmaceuticals Inc	2.95	$ 7.990 Millions	$ 3 Millions
Electromed Inc	2.95	$ 12.621 Millions	$ 4 Millions
Coherus Oncology inc	2.95	$ 143.557 Millions	$ 49 Millions
Dentsply Sirona Inc	2.93	$ 1,867.000 Millions	$ 636 Millions
Caredx Inc	2.93	$ 55.978 Millions	$ 19 Millions
Illumina Inc	2.89	$ 1,737.000 Millions	$ 601 Millions
T2 Biosystems Inc	2.87	$ 12.996 Millions	$ 5 Millions

Date modified: 2026-06-23T19:22:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.